Seoulin Bioscience Co.,Ltd. (KOSDAQ:038070)

Seoulin Bioscience Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 4, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	59,094	61,462	78,767	97,546	174,747	107,487
Market Cap Growth	-4.16%	-21.97%	-19.25%	-44.18%	62.58%	56.83%
Enterprise Value	39,338	39,202	46,863	48,995	136,075	93,693
Last Close Price	6850.00	7110.00	8862.64	10842.90	19192.91	11739.20
PE Ratio	30.31	21.09	-	9.60	11.21	21.97
PS Ratio	0.77	0.82	0.88	0.93	2.17	1.65
PB Ratio	0.68	0.71	0.92	1.10	2.28	1.75
P/TBV Ratio	0.71	0.74	0.96	1.17	2.36	1.82
P/FCF Ratio	100.42	-	-	-	21.89	32.74
P/OCF Ratio	81.80	-	84.64	-	19.60	29.17
EV/Sales Ratio	0.51	0.52	0.52	0.47	1.69	1.44
EV/EBITDA Ratio	24.84	16.92	12.39	4.80	14.51	14.52
EV/EBIT Ratio	108.07	41.15	18.79	5.33	18.26	20.96
EV/FCF Ratio	66.85	-	-	-	17.04	28.54
Debt / Equity Ratio	0.11	0.04	0.08	0.20	0.21	0.01
Debt / EBITDA Ratio	5.92	1.59	1.78	1.74	1.68	0.12
Debt / FCF Ratio	15.82	-	-	-	1.97	0.23
Asset Turnover	0.73	0.70	0.72	0.77	0.75	0.82
Inventory Turnover	2.59	2.35	3.57	5.15	4.63	4.09
Quick Ratio	1.46	2.30	1.77	1.35	1.44	2.13
Current Ratio	2.57	4.39	2.60	1.88	1.77	3.06
Return on Equity (ROE)	3.12%	3.65%	-2.67%	12.78%	23.03%	7.83%
Return on Assets (ROA)	0.21%	0.55%	1.25%	4.23%	4.34%	3.52%
Return on Capital (ROIC)	0.24%	0.65%	1.57%	5.78%	6.03%	4.52%
Return on Capital Employed (ROCE)	0.40%	1.10%	2.90%	10.30%	9.70%	6.90%
Earnings Yield	3.59%	4.74%	-0.15%	10.41%	8.92%	4.55%
FCF Yield	1.00%	-7.58%	-0.02%	-4.94%	4.57%	3.05%
Dividend Yield	1.43%	1.37%	-	-	-	-
Payout Ratio	39.78%	28.70%	-	7.86%	4.93%	14.74%
Buyback Yield / Dilution	-7.12%	0.50%	19.46%	-23.72%	0.07%	1.26%
Total Shareholder Return	-5.69%	1.87%	19.46%	-23.72%	0.07%	1.26%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.